Parameters of free radical oxidation in the blood of patients with non-small cell lung cancer and COVID-19 in anamnesis

The role of redox processes imbalance in the onset of malignant transformation and neoplasia progression is well known. It has been suggested that COVID-19 is a metabolic disease. Reactive oxygen species (ROS) and glutathione-dependent antioxidant system contribute much to its development. Moreover, there is an opinion that it is necessary to precisely identify free radical oxidation products that contribute to a redox status imbalance in the blood of COVID-19 patients. The purpose of the study is to evaluate the intensity of lipid peroxidation and parameters of the antioxidant system in the blood cells of lung cancer patients with COVID-19 in anamnesis.